Consortia Management

Negotiate the buying and selling of data rights for companies and consortiums to enable submission in global markets.

We negotiate the buying and selling of data rights for companies and consortiums to enable submission in global markets.

What is it?

The core principle of REACH is "one substance, one registration." This requires manufacturers and importers of the same substance to collaborate on a single joint registration dossier. By sharing technical data and costs through a lead registrant or a formal consortium, companies avoid duplicate testing and streamline their path to market.

This collaboration is governed by a strict legal framework mandating that all data and cost-sharing be fair, transparent, and non-discriminatory. These obligations are ongoing; even after the initial registration, dossiers and financial records must be continuously maintained to accommodate new market entrants and updated safety information.

The REACH model has gone global. Countries including the UK, South Korea, Turkey, China, and Ukraine have implemented similar legislation, creating a massive demand for EU-generated data. International harmonization allows companies to leverage existing scientific studies for multiple regulatory submissions across different regions, reduce costs, ensure consistent classification and lablleing, and minimize risks assoicated with new, potientally conflicting data being generated.

As global regulations converge, effective data management is no longer optional—it is a strategic necessity. Professional consortium management ensures that proprietary information is protected while providing a structured, legally compliant environment for cost recovery and long-term regulatory success.

What we offer

Consortium Formation & Management: Full-service establishment of substance-specific groups, including the drafting of agreements and the management of steering committees.

  • Independent Third-Party Secretariats: Acting as a neutral trustee to handle sensitive business information (such as production volumes) to ensure compliance with competition laws.
  • Cost-Sharing & Financial Management: Development of transparent cost-sharing models, including the calculation of Letter of Access (LoA) prices and management of reimbursement mechanisms.
  • Global Data Leveraging: Sourcing and managing EU-generated data for use in "REACH-like" submissions worldwide (e.g., UK REACH, KKDIK, K-REACH) and other regulatory filings (eg. biocides, food contact, cosmetics).
  • Letter of Access (LoA) Services: Full handling of LoA inquiries, from legal agreement execution to the secure delivery of joint submission credentials.
  • Joint Submission Coordination: Technical management of the Lead Registrant dossier and the coordination of co-registrants via REACH-IT or local equivalents.
  • Dossier Maintenance & Updates: Continuous monitoring of registration dossiers to ensure they remain compliant with the latest regulatory decisions and scientific findings.
  • Dispute Resolution: Providing expert mediation and support during data-sharing negotiations to ensure continuous and uninterrupted market access.
Yordas Team Working

Expert consultants

Yordas has over 15 years of extensive experience managing and working with SIEF and consortia. In our capacity as lead registrant for >55 substances we provide our clients with bespoke and cost effective solutions for navigating complex data sharing requirements in the EU and globally. We work to ensure cost sharing is carried out transparently and companies meet their obligations in a timely manner.

esea (6)

Client focused delivery

Our services include full managerial and operational support for lead registrants and consortia, financial management of letter access calculations and reimbursements, joint registrants data sharing, and support with data sharing negotiations for use of data in other jurisdictions.